Hantz Financial Services Inc. Sells 6,328 Shares of The Cooper Companies, Inc. $COO

Hantz Financial Services Inc. lessened its position in The Cooper Companies, Inc. (NASDAQ:COO) by 6.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 88,103 shares of the medical device company’s stock after selling 6,328 shares during the quarter. Hantz Financial Services Inc.’s holdings in Cooper Companies were worth $6,269,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. New York Life Investment Management LLC lifted its holdings in shares of Cooper Companies by 0.7% in the 2nd quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company’s stock worth $2,136,000 after acquiring an additional 210 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Cooper Companies by 1.8% in the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 34,320 shares of the medical device company’s stock worth $2,442,000 after acquiring an additional 600 shares during the last quarter. Teacher Retirement System of Texas lifted its holdings in shares of Cooper Companies by 4.1% in the 2nd quarter. Teacher Retirement System of Texas now owns 30,366 shares of the medical device company’s stock worth $2,161,000 after acquiring an additional 1,191 shares during the last quarter. Y Intercept Hong Kong Ltd increased its stake in Cooper Companies by 2,567.7% in the 2nd quarter. Y Intercept Hong Kong Ltd now owns 83,046 shares of the medical device company’s stock worth $5,910,000 after buying an additional 79,933 shares during the period. Finally, Envestnet Asset Management Inc. increased its stake in Cooper Companies by 0.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 644,569 shares of the medical device company’s stock worth $45,868,000 after buying an additional 2,322 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.8%

NASDAQ COO opened at $70.11 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The company has a market capitalization of $13.94 billion, a price-to-earnings ratio of 34.54, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company’s 50-day simple moving average is $69.48 and its two-hundred day simple moving average is $73.08. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $107.84.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its board has approved a share repurchase plan on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

Insider Activity at Cooper Companies

In other news, COO Daniel G. Mcbride purchased 3,000 shares of the business’s stock in a transaction on Tuesday, September 2nd. The shares were acquired at an average cost of $65.04 per share, with a total value of $195,120.00. Following the completion of the acquisition, the chief operating officer owned 63,120 shares of the company’s stock, valued at $4,105,324.80. This trade represents a 4.99% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of the business’s stock in a transaction on Monday, September 29th. The stock was purchased at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the completion of the acquisition, the director directly owned 5,777 shares of the company’s stock, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 17,975 shares of company stock valued at $1,216,346 over the last three months. Company insiders own 1.98% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on COO shares. Barclays started coverage on shares of Cooper Companies in a research note on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target on the stock. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. BNP Paribas Exane raised shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. Robert W. Baird dropped their price target on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating on the stock in a research report on Thursday, August 28th. Finally, Mizuho dropped their price target on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $84.77.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.